Philips
About: Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, and image-guided therapy solutions. The connected care segment (around 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal care products.
Employees: 67,823
0
Funds holding %
of 7,296 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
20% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 30
9% more repeat investments, than reductions
Existing positions increased: 104 | Existing positions reduced: 95
2% more capital invested
Capital invested by funds: $1.45B [Q4 2024] → $1.48B (+$26.6M) [Q1 2025]
0.16% more ownership
Funds ownership: 6.02% [Q4 2024] → 6.18% (+0.16%) [Q1 2025]
0% more funds holding in top 10
Funds holding in top 10: 1 [Q4 2024] → 1 (+0) [Q1 2025]
9% less call options, than puts
Call options by funds: $19.9M | Put options by funds: $21.8M
1% less funds holding
Funds holding: 312 [Q4 2024] → 308 (-4) [Q1 2025]
Research analyst outlook
We haven’t received any recent analyst ratings for PHG.
Financial journalist opinion
Based on 7 articles about PHG published over the past 30 days
Neutral
GlobeNewsWire
1 week ago
Philips Foundation 2024 Annual Report: expanding access to quality healthcare for 46.5 million people
Amsterdam, the Netherlands – Marking its tenth anniversary, Philips Foundation today released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around the world – a significant increase from 28 million the year before. This progress was driven by 22 new initiatives and five new early-stage capital impact investments that expanded Philips Foundation's reach, channeling Philips' health technology expertise to help address the growing burden of non-communicable diseases and maternal health challenges, predominantly at the primary care level in underserved communities. “Today, half of the global population still does not have access to healthcare. Innovation and new digital technologies, combined with an ecosystem of partners, can improve health outcomes and make progress towards a future where quality healthcare is within reach for everyone,” said Marnix van Ginneken, Chair of the Board of the Philips Foundation. “The Foundation's tenth anniversary marks an important milestone, demonstrating our continued commitment to addressing the critical needs of the world's most vulnerable populations.” Since it was established in 2014, Philips Foundation has brought healthcare solutions to some of the most remote and underserved regions across the globe – from rural clinics in Africa to urban slums in Latin America. These efforts included groundbreaking work to combat neglected diseases such as rheumatic heart disease in collaboration with the World Heart Federation, and cross-continental ultrasound training programs with RAD-AID International, enabling frontline healthcare workers to detect and prevent life-threatening conditions for people living in low-resource settings. Philips Foundation continues to build scalable healthcare models by providing ventures early-stage capital through Philips Foundation Impact Investments, supporting locally driven innovation and accelerating access to healthcare in underserved settings. In 2024, Philips Foundation Impact Investments expanded its portfolio with new ventures from India and Latin America, reinforcing its commitment to financially viable, locally rooted healthcare innovation. “Combining the impact of long-term strategic collaborations and new, innovative partnerships and early-stage investments, the Foundation has helped to embed healthcare innovations in the communities where they're most needed, improving healthcare access,” Margot Cooijmans, Director of Philips Foundation and Philips Foundation Impact Investments, said. “We continue to increase the number of people that we reach with quality healthcare, bringing us closer to our ambition to reach 100 million people annually by 2030.” To read the full 2024 Annual Report, click here.
Neutral
GlobeNewsWire
1 week ago
Philips announces exchange ratio for 2024 dividend
June 5, 2025 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), today announced that the exchange ratio for the dividend for the year 2024 is 1 new common share for every 23.6353 existing common shares. This ratio was based on the volume weighted average price on Euronext Amsterdam of May 30, June 2, and 3, 2025, of EUR 20.0600 and was calculated in a manner that the gross dividend in shares will be approximately equal to EUR 0.85.
Neutral
GlobeNewsWire
1 week ago
Philips to repurchase up to 6 million shares to cover long-term incentive plans
June 4, 2025 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) today announced that it will repurchase up to 6 million shares to cover certain of its obligations arising from its long-term incentive plans. At the current share price, the shares represent an amount of up to approximately EUR 125 million.
Neutral
GlobeNewsWire
1 week ago
Philips launches intelligent 3D imaging in Europe to empower faster stroke care, helping physicians save time, brain, and lives
Demonstrated at LINNC Paris 2025, the company's latest release of SmartCT delivers fast, intelligent 3D imaging in the Angio suite — helping physicians act with greater speed and confidence during a range of critical neurovascular procedures
Neutral
Business Wire
2 weeks ago
Philips and March of Dimes Bring Maternal and Pregnancy Health Content to Philips Avent Pregnancy+ App
CAMBRIDGE, Mass. & ARLINGTON, Va.--(BUSINESS WIRE)--Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and March of Dimes, the nation's leading nonprofit fighting for the health of all moms and babies, today announced a collaboration aimed at improving maternal health education through the Philips Avent Pregnancy+ app. Philips will integrate essential March of Dimes content into the app to help improve health literacy and create awareness for topics such as preparing fo.
Neutral
GlobeNewsWire
3 weeks ago
Philips launches RADIQAL study to generate real-world evidence for new ultra-low X-ray dose technology in coronary procedures
May 20, 2025 Prospective, randomized, unblinded, comparative, international, multi-center clinical investigation 824 patients across 6 hospitals in Spain, Czech Republic, Denmark and the US Primary objective is to demonstrate that the new technology can reduce overall patient radiation dose without affecting coronary procedure performance. Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of the RADIQAL (Radiation Dose and Image Quality Trial) trial.
Neutral
GlobeNewsWire
3 weeks ago
Philips launches real-time 3D intracardiac imaging in Europe, expanding access to minimally invasive heart procedures
May 19, 2025 VeriSight Pro 3D ICE catheter is a pioneering innovation — a miniaturized ultrasound probe embedded at the tip of a thin, steerable catheter, navigated through the vascular system into the heart chambers to deliver high-quality 2D and 3D images in real time Catheter offers enhanced procedural guidance without the need for general anesthesia, supporting more efficient and patient-friendly care for structural heart disease Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the introduction of its VeriSight Pro 3D Intracardiac Echocardiography (ICE) catheter in Europe. Building on its success in the United States, VeriSight Pro brings real-time 3D imaging directly inside the heart, helping physicians perform procedures with greater clarity — without the need for general anesthesia.
Neutral
GlobeNewsWire
1 month ago
Philips successfully prices offering of Notes for EUR 1 billion to be used for repayment of existing debt and to finance eligible green projects
May 15, 2025 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the successful pricing of its offering of EUR 500 million fixed rate notes due 2030 and EUR 500 million fixed rate notes due 2035 (the “Notes”) under its European Medium Term Note (EMTN) program. The net proceeds will be used for general corporate purposes, the repayment of 2026 debt maturities, and to refinance or finance any Eligible Projects as defined in Philips' Sustainable Finance Framework.
Neutral
GlobeNewsWire
1 month ago
Philips Future Health Index 2025: AI poised to transform global healthcare, urging leaders to act now
May 15, 2025 AI has the power to cut care delays and manage data overload, but trust gaps among clinicians and patients threaten to slow adoption and impact Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has released its 10th annual Future Health Index (FHI) report, highlighting the growing strain on global healthcare systems. The FHI 2025 Report, the largest global survey of its kind analyzing key concerns of healthcare professionals and patients, indicates AI holds promise for transforming care delivery. However, gaps in trust threaten to stall progress at a time when innovation is most needed. “The need to transform healthcare delivery has never been more urgent,” said Carla Goulart Peron, M.D., Chief Medical Officer at Philips. “In more than half of the 16 countries surveyed, patients are waiting nearly two months or more for specialist appointments, with waits in Canada and Spain extending to four months or longer. As healthcare systems face mounting pressures, AI is rapidly emerging as a powerful ally, offering unprecedented opportunities to transform care and overcome today's toughest challenges.” Long waits, worsening outcomes The FHI 2025 report reveals 33% of patients have experienced worsening health due to delays in seeing a doctor, and more than 1 in 4 end up in the hospital due to long wait times. “Cardiac patients face especially dangerous delays, with 31% being hospitalized before even seeing a specialist. Without urgent action, a projected shortfall of 11 million health workers by 2030 could leave millions without timely care,” Dr. Peron added. Clinician burnout and data burdens call for digital relief More than 75% of healthcare professionals report losing clinical time due to incomplete or inaccessible patient data, with one-third losing over 45 minutes per shift, adding up to 23 full days a year lost by each professional. “These inefficiencies amplify stress on already understaffed teams and contribute to burnout,” said Gretchen Brown, RN, VP and Chief Nursing Information Officer at Stanford Health Care. “Recognizing this, as clinicians, we see AI as a solution and understand that delayed adoption can also carry major risks.” Of the nearly 2,000 healthcare professionals surveyed, if AI is not implemented:
Neutral
Business Wire
1 month ago
Philips Future Health Index 2025 Report Highlights Significant Trust Gap in Healthcare AI Between Clinicians and Patients
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today unveiled its 2025 Future Health Index U.S. report, “Building trust in healthcare AI,” spotlighting the state of healthcare and uncovering a significant trust gap between healthcare professionals (HCPs) and patients around the role of AI in healthcare. This 10th edition report, commissioned by Philips, reveals a healthcare system under mounting strain and signals that AI can help.
Charts implemented using Lightweight Charts™